Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.4 now appears on the page, replacing the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-18T05:32:12.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page footer has an updated software/UI revision label from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:47:44.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T14:30:38.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added the MeSH term Malignant fibrous histiocytoma to the study's indexing terms.
    Difference
    0.1%
    Check dated 2026-03-29T04:28:10.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T20:44:30.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; Revision: v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-07T08:47:01.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.